• phone icon505-272-5485
Publications in VIVO
 

Raissy, Hengameh H Research  Professor

Positions

Principal investigator for CARE Network, CAMP and AsthmaNet.

 

My research interest is “pediatric asthma.” We have investigated the noninvasive methods for comparing the potency and systemic effect s of the inhaled corticosteroids using fraction of exhaled nitric oxide (FeNO) and urinary free cortical (UFC) in children with asthma. The same model was used to compare the topical and systemic effect of a low dose inhaled corticosteroid to a leukotriene modifier.  Subsequently, we investigated the relationship between asthma severity and endogenous cortisol excretion combining our data and available data from CAMP. Furthermore, we evaluated the potential pro-inflammatory, bronchial hyperreactivity or direct antagonistic effects of S-albuterol when used for acute asthma exacerbation.  In our latest completed project, we compare pretreatment with albuterol to montelukast in children with exercise induced bronchospasm (EIB) which was identified as “a best evidence Review” by Medscape from WebMD.
Recently, we have been added as a satellite site to “The Childhood Asthma Research and Education, (CARE) Network.” The CARE network was established in 1999 by the National Heart, Lung and Blood Institute (NHLBI) to evaluate treatments for children with asthma, providing  data to fill the gap in the literature and share their findings with the health care community.  Currently, we are participating in two studies,TREXA and MIST.

selected publications

selected publications as collaborator

research overview

  • My research interest is “pediatric asthma.” We have investigated the noninvasive methods for comparing the potency and systemic effect s of the inhaled corticosteroids using fraction of exhaled nitric oxide (FeNO) and urinary free cortical (UFC) in children with asthma. The same model was used to compare the topical and systemic effect of a low dose inhaled corticosteroid to a leukotriene modifier.  Subsequently, we investigated the relationship between asthma severity and endogenous cortisol excretion combining our data and available data from CAMP. Furthermore, we evaluated the potential pro-inflammatory, bronchial hyperreactivity or direct antagonistic effects of S-albuterol when used for acute asthma exacerbation.  In our latest completed project, we compare pretreatment with albuterol to montelukast in children with exercise induced bronchospasm (EIB) which was identified as “a best evidence Review” by Medscape from WebMD.
    Recently, we have been added as a satellite site to “The Childhood Asthma Research and Education, (CARE) Network.” The CARE network was established in 1999 by the National Heart, Lung and Blood Institute (NHLBI) to evaluate treatments for children with asthma, providing  data to fill the gap in the literature and share their findings with the health care community.  Currently, we are participating in two studies,TREXA and MIST.